🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Laura Riva

Scripps Research Institute

ORCID: 0000-0003-2414-7341

Also affiliated with California Institute for Biomedical Research

MedicineImmunology and MicrobiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.500Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Synthetic lethality-based prediction of anti-SARS-CoV-2 targets

iScience(2022)10.1016/j.isci.2022.104311
Top 38%
0.500DataRank
Top 38%10 citations

Kuoyuan Cheng, Nishanth Ulhas Nair, Laura Martin‐Sancho, Sanju Sinha, Yuan Pu +7 more

Papers

Driven by 18 papers — median percentile 62. Top paper: “MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells”.

MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells

Cell Reports(2021)10.1016/j.celrep.2020.108628
N/A
10.1DataRank · unranked
416 citations

Laura Riva, Yuan Pu, Laura Martin‐Sancho, Jun Kanamune, Yuki Yamamoto +11 more

Restriction factor compendium for influenza A virus reveals a mechanism for evasion of autophagy

Nature Microbiology(2021)10.1038/s41564-021-00964-2
N/A
1.5DataRank · unranked
49 citations

Shashank Tripathi, Ariel Rodríguez-Frandsen, Lars Pache, María Teresa Sánchez-Aparicio, Michael McGregor +25 more

Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets

Molecular Systems Biology(2021)10.15252/msb.202110260
N/A
1.3DataRank · unranked
49 citations

Laura Martin‐Sancho, Lipika R. Pal, Yuan Pu, Laura Riva, Xin Yin +5 more

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

Nature(2020)10.1038/s41586-020-2577-1
N/A
1.0DataRank · unranked
858 citations

Shuofeng Yuan, Xin Yin, Laura Martin‐Sancho, Naoko Matsunaga, Lars Pache +40 more

Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

Nature(2021)10.1038/s41586-021-03431-4
N/A
0.806DataRank · unranked
214 citations

Xin Yin, Xiangzhi Meng, Jasper Fuk‐Woo Chan, Zi‐Wei Ye, Laura Riva +40 more

Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity

ACS Infectious Diseases(2022)10.1021/acsinfecdis.2c00008
N/A
0.752DataRank · unranked
24 citations

Laura Martin‐Sancho, Ranjala Ratnayake, Kris M. White, Laura Riva, Qi-Yin Chen +20 more

A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.16.044016
N/A
0.710DataRank · unranked
113 citations

Shuofeng Yuan, Xin Yin, Laura Martin‐Sancho, Naoko Matsunaga, Sebastian Burgstaller-Muehlbacher +26 more

Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA

Molecular Cell(2022)10.1016/j.molcel.2022.06.010
N/A
0.584DataRank · unranked
48 citations

João I. Mamede, Derrick Lau, Narae Ahn, María Teresa Sánchez-Aparicio, Joshua Temple +16 more

Synthetic lethality-based prediction of anti-SARS-CoV-2 targets

iScience(2022)10.1016/j.isci.2022.104311
Top 38%
0.500DataRank
Top 38%10 citations

Kuoyuan Cheng, Nishanth Ulhas Nair, Laura Martin‐Sancho, Sanju Sinha, Yuan Pu +7 more

An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo

Cell Reports(2024)10.1016/j.celrep.2024.114929
N/A
0.398DataRank · unranked
10 citations

Su Tang, Xuelin Bian, Maloy Kumar Parai, Inna V. Krieger, Armando Flores +27 more

Drug repurposing screens identify chemical entities for the development of COVID-19 interventions

Nature Communications(2021)10.1038/s41467-021-23328-0
N/A
0DataRank · unranked
130 citations

Nathan Beutler, Karen C. Wolff, Melanie G. Kirkpatrick, Emily Chen, Tu-Trinh Nguyen +27 more

The therapeutic monoclonal antibody bamlanivimab does not enhance SARS‑CoV-2 infection by FcR-mediated mechanisms

Research Square(2022)10.21203/rs.3.rs-2285240/v1
N/A
0DataRank · unranked
1 citations

Christopher M. Wiethoff, Patricia Brown‐Augsburger, Shawn Berens, Jamie L. Blackbourne, Ling Liu +25 more

The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms

Pathogens(2023)10.3390/pathogens12121408
N/A
0DataRank · unranked
5 citations

Christopher M. Wiethoff, Patricia Brown‐Augsburger, Shawn Berens, Jamie L. Blackbourne, Ling Liu +25 more

An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo

UNC Libraries(2024)10.17615/wwq1-b853
N/A
0DataRank · unranked
0 citations

Maloy Kumar Parai, Timothy P. Sheahan, Jeremy P. Wood, Bian, Xuelin, Inna V. Krieger +27 more

The interplay between dormant mutated cells and tumor promotion by chronic tissue damage in determining cancer risk

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.24.577147
N/A
0DataRank · unranked
0 citations

Eve Kandyba, Kyle Halliwill, Reyno Delrosario, Quân Tran, Nora Bayani +11 more

Synthetic lethality-based prediction of anti-SARS-CoV-2 targets

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.14.460408
N/A
0DataRank · unranked
0 citations

Kuoyuan Cheng, Nishanth Ulhas Nair, Laura Martin‐Sancho, Sanju Sinha, Yuan Pu +7 more

Optimization of a micro-scale air–liquid-interface model of human proximal airway epithelium for moderate throughput drug screening for SARS-CoV-2

Respiratory Research(2025)10.1186/s12931-025-03095-y
N/A
0DataRank · unranked
4 citations

Tammy M. Rickabaugh, Arjit Vijey Jeyachandran, Constance Yuen, Maisam Ghannam, Abdo Durra +18 more

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication

Cell Reports(2021)10.1016/j.celrep.2021.108940
N/A
0DataRank · unranked
119 citations

Arun Sharma, Arunachalam Ramaiah, Chandani Sen, Arunima Purkayastha, Donald B. Kohn +23 more